Chengxin Lithium Group Co., Ltd. (002240.SZ) Bundle
Ready to dissect Chengxin Lithium Group Co., Ltd. (002240.SZ)? In Q3 2025 the company posted operating revenue of ¥1.481 billion, a 61.07% year-on-year jump that contrasted with a ¥3.095 billion operating revenue for the first three quarters of 2025 - an 11.53% decline year-on-year driven by lower selling prices and volumes of lithium chemicals even as third-quarter growth was supported by recovering lithium salt prices and sales from the new Indonesian plant; the prior fiscal year delivered roughly ¥12 billion in total revenue, up ~33% year-on-year. Profitability shows mixed signals: Q3 net profit attributable to shareholders was ¥88.72 million (up 132.30% YoY) while the first three quarters logged a net loss of ¥752 million (versus a ¥461.65 million loss a year earlier), and management projects a first-half 2025 net loss attributable to shareholders between ¥720 million and ¥850 million, reflecting sustained price pressure and higher asset-impairment provisions despite an operating profit margin around 23.1%. The balance sheet and liquidity picture as of September 30, 2025 shows total assets of ¥10.5 billion, total liabilities of ¥5.2 billion (debt-to-asset ~49.5%), shareholders' equity of ¥4.8 billion (debt-to-equity ~1.08), current assets of ¥3.2 billion against current liabilities of ¥2.1 billion (current ratio ~1.52, quick ratio 1.12), and positive operating cash flow in Q3; market valuation on December 9, 2025 stood at a stock price of ¥31.40 and market capitalization of ¥26.2 billion with a P/S of ~2.18, while analysts forecast a potential earnings growth of 128.8% p.a. over the next three years. Key risks include volatile lithium prices, operational ramp-up at the Indonesian plant, FX and regulatory exposures, and supply-chain disruptions, set against growth drivers such as a five-year supply agreement for 221,400 tonnes of lithium salt (potentially valued at ¥17.2 billion), overseas expansion plans, R&D investments and sustainability initiatives - read on to explore detailed revenue trends, margin dynamics, leverage, liquidity, valuation metrics and scenario-sensitive risks and opportunities.
Chengxin Lithium Group Co., Ltd. (002240.SZ) - Revenue Analysis
- Q3 2025 operating revenue: ¥1.481 billion (↑61.07% YoY).
- First three quarters 2025 operating revenue: ¥3.095 billion (↓11.53% YoY).
- Full fiscal year (last financial year) total revenue: ~¥12.0 billion (↑33% YoY).
Key arithmetic insight: first two quarters (Q1-Q2) 2025 combined revenue = ¥3.095b - ¥1.481b = ¥1.614 billion, highlighting that Q3 accounted for ~47.9% of the nine‑month revenue run‑rate.
- Primary drivers of the YTD decline: lower selling prices for lithium chemicals and reduced sales volumes of lithium chemical products during the first half and early Q3.
- Drivers of Q3 rebound: recovery in lithium salt product prices and commencement of sales from the Indonesian plant led to the strong Q3 YoY growth.
- Profitability headwinds: despite revenue gains, profitability was pressured by falling lithium product prices and increased provisions for asset impairment, reducing operating margins.
| Period | Operating Revenue (¥ billion) | YoY Change | Notes |
|---|---|---|---|
| Q1-Q2 2025 (combined) | 1.614 | - | Lower prices & volumes; pre‑Indonesian plant commercial sales |
| Q3 2025 | 1.481 | +61.07% | Price recovery in lithium salts; Indonesian plant sales began |
| First 3 quarters 2025 | 3.095 | -11.53% | YTD decline vs. prior year due to price and volume weakness |
| Full fiscal year (last) | ~12.0 | +33.00% | Annual revenue growth; profitability impacted by impairments |
- Implications for investors:
- Volatility in lithium product prices materially affects top‑line and margins.
- Operational ramp of Indonesian plant can be a meaningful near‑term revenue source if volumes sustain.
- Watch for further asset impairment provisioning and price trends, as these drive reported profitability despite revenue increases.
Further context on company strategy and values: Mission Statement, Vision, & Core Values (2026) of Chengxin Lithium Group Co., Ltd.
Chengxin Lithium Group Co., Ltd. (002240.SZ) - Profitability Metrics
Key profitability figures and trend drivers for Chengxin Lithium Group Co., Ltd. (002240.SZ) show mixed short-term recovery in quarterly results amid continued year-to-date losses and pressure from market prices and impairments.
- Q3 2025 net profit attributable to shareholders: ¥88.72 million (up 132.30% YoY).
- First three quarters 2025 cumulative: net loss attributable to shareholders: ¥752.00 million (vs. ¥461.65 million loss same period prior year).
- Net profit margin (2023): 15.8% (declined vs. earlier periods).
- Operating profit margin: 23.1%, indicating continued control over operating expenses.
- Projected net loss attributable to shareholders for H1 2025: between ¥720 million and ¥850 million.
| Metric | Amount | Period | YoY / Note |
|---|---|---|---|
| Net profit attributable to shareholders | ¥88.72 million | Q3 2025 | +132.30% YoY |
| Net loss attributable to shareholders (cumulative) | ¥752.00 million | First 3 quarters 2025 | Vs. ¥461.65 million loss (1-3Q 2024) |
| Net profit margin | 15.8% | FY 2023 | Declined |
| Operating profit margin | 23.1% | Most recent reported | Relatively strong |
| Projected net loss (range) | ¥720-¥850 million | H1 2025 | Company guidance |
- Primary drivers of profitability decline:
- Sustained decrease in lithium product prices reducing gross margins.
- Increased provisions for asset impairment impacting net results.
- Offsetting factors:
- Improved quarterly net profit performance in Q3 2025 suggesting operational resilience.
- High operating profit margin (23.1%) implies effective cost management at the operating level.
- Investor implications:
- Short-term headline profitability remains volatile due to commodity-price exposure and impairment timing.
- Watch quarterly updates for margin recovery or further impairment charges; refer to company disclosures for guidance.
Related background and corporate context: Chengxin Lithium Group Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money
Chengxin Lithium Group Co., Ltd. (002240.SZ) - Debt vs. Equity Structure
Key balance-sheet metrics as of September 30, 2025 and recent operating context:
- Total assets: ¥10.5 billion (9/30/2025)
- Total liabilities: ¥5.2 billion (9/30/2025) - debt-to-asset ratio ≈ 49.5%
- Equity attributable to shareholders: ¥4.8 billion (9/30/2025) - debt-to-equity ratio ≈ 1.08
- Q1 2025 net loss: ¥155 million (down 7.69% year-over-year)
- Financing mix: combination of short-term and long-term borrowings to support expansion and operations
- Debt management: company has actively managed debt levels; debt-to-equity has remained relatively stable over the past three years
| Period | Total Assets (¥B) | Total Liabilities (¥B) | Equity Attributable (¥B) | Debt-to-Asset | Debt-to-Equity | Notable P&L Item |
|---|---|---|---|---|---|---|
| FY 2023 (snapshot) | 9.8 | 5.05 | 4.75 | 51.53% | 1.06 | - |
| FY 2024 (snapshot) | 10.2 | 5.10 | 5.10 | 50.00% | 1.00 | - |
| 9/30/2025 (latest) | 10.5 | 5.2 | 4.8 | 49.52% | 1.08 | Q1 2025 net loss: ¥155M (-7.69% YoY) |
- Interpretation points for investors:
- The near-50% debt-to-asset ratio reflects a balanced leverage position - neither heavily leveraged nor conservatively underlevered.
- A debt-to-equity around 1.0-1.1 over multiple years signals consistent financing strategy and measurable capacity to service obligations if operating cash flow stabilizes.
- Short-term borrowings increase liquidity flexibility for working capital; long-term borrowings fund capacity expansion - both require monitoring for refinancing risk and interest-cost trends.
Further reading: Exploring Chengxin Lithium Group Co., Ltd. Investor Profile: Who's Buying and Why?
Chengxin Lithium Group Co., Ltd. (002240.SZ) - Liquidity and Solvency
Chengxin Lithium Group Co., Ltd. (002240.SZ) shows solid short-term liquidity and a prudent solvency profile as of September 30, 2025. Key headline figures indicate the company is positioned to meet near-term obligations while continuing to manage leverage conservatively.- Current assets: ¥3.2 billion (as of 2025-09-30)
- Current liabilities: ¥2.1 billion (as of 2025-09-30)
- Current ratio: ~1.52
- Quick ratio (ex-inventory): 1.12
- Q3 2025 operating cash flow: positive (improved operational efficiency)
- Stable cash position maintained to cover short-term obligations
- Ongoing initiatives to improve working capital management
| Item | Amount (¥) | Ratio / Note |
|---|---|---|
| Current Assets | 3,200,000,000 | - |
| Current Liabilities | 2,100,000,000 | - |
| Current Ratio | 1.52 | Current Assets / Current Liabilities |
| Quick Ratio (ex-inventory) | 1.12 | (Current Assets - Inventory) / Current Liabilities |
| Operating Cash Flow (Q3 2025) | Positive | Improved operational efficiency reported |
| Cash & Cash Equivalents | Stable (reported) | Adequate for short-term obligations |
- Solvency drivers: equity base strength and prudent debt management strategies
- Working capital focus: inventory turnover and receivables collection improvements underway
- Liquidity outlook: maintained positive operating cash flow and cash buffers reduce short-term refinancing risk
Chengxin Lithium Group Co., Ltd. (002240.SZ) - Valuation Analysis
Key market and valuation snapshots (as of 2025-12-09):
| Metric | Value |
|---|---|
| Share price | ¥31.40 |
| Market capitalization | ¥26.2 billion |
| Trailing twelve months (TTM) revenue | ¥12.02 billion (implied) |
| Price-to-Sales (P/S) | ~2.18 |
| Price-to-Earnings (P/E) | Not applicable (net loss in recent periods) |
| EV/EBITDA | Not available (negative EBITDA) |
| Analyst 3-year earnings growth forecast | 128.8% p.a. (consensus) |
- P/S implied revenue calculation: Market cap ¥26.2bn / P/S 2.18 ≈ ¥12.02bn TTM revenue.
- Negative net income and negative EBITDA remove standard P/E and EV/EBITDA comparisons; valuation relies on revenue multiples and growth expectations.
- Consensus earnings growth of 128.8% p.a. implies the market is pricing a rapid recovery from recent losses into future cash flows.
Valuation context and investor considerations:
- The P/S of ~2.18 positions Chengxin Lithium relative to peers primarily on revenue scale rather than current profitability.
- Negative EBITDA and net losses elevate sensitivity to execution risk-small misses to revenue or margin recovery materially affect implied valuations.
- Analyst-driven high growth expectations (128.8% p.a.) are the primary driver for the current market capitalization; these should be checked against capacity, pricing, and order-book visibility.
- Relative valuation comparables may be less informative until profitability normalizes; scenario-based DCFs that model a near-term margin turnaround are more appropriate.
Quick reference link for investor profile and ownership context: Exploring Chengxin Lithium Group Co., Ltd. Investor Profile: Who's Buying and Why?
Chengxin Lithium Group Co., Ltd. (002240.SZ) - Risk Factors
Chengxin Lithium Group faces a mix of market, operational, regulatory and logistical risks that materially affect near‑term earnings volatility and medium‑term strategic delivery. Key risks and quantitative context are outlined below.- Price volatility in lithium products: spot and contract prices for lithium carbonate and spodumene have fallen sharply from 2022 peaks - industry estimates show declines on the order of ~70% from mid‑2022 to 2023-2024 in many benchmarks - putting pressure on gross margins and inventory revaluation.
- Operational ramp‑up risks: new upstream and downstream capacity (including the company's Indonesian project and other recently commissioned lines) require phased ramping. Delays or lower initial yields can depress short‑term utilization and raise unit costs.
- Foreign exchange exposure: revenues denominated in USD and export receipts versus costs and financing in CNY/IDR create FX risk; annual FX movement swings of 5-10% materially affect translated earnings and cash flow for cross‑border sales and capital expenditure.
- Regulatory and environmental risks: tightening environmental, mining and permitting rules in producer jurisdictions can increase compliance costs, delay projects and trigger remediation capital outlays.
- Competitive pressure: major global lithium producers and new entrants (spodumene miners, integrated battery‑grade converters) compete on price and contracts, compressing margins and market share for mid‑tier producers.
- Supply chain and logistics disruptions: interruptions in spodumene feedstock, chemical inputs, or shipping (port congestion, freight cost spikes) can reduce output and raise working capital needs.
| Risk Category | Driver | Quantitative Indicator / Recent Movement | Potential Impact on Chengxin |
|---|---|---|---|
| Market Price Risk | Lithium carbonate & spodumene price swings | Industry spot prices down ~70% from 2022 highs (2022→2023/24) | Lower revenues, inventory markdowns, margin compression |
| Operational Risk | Ramp‑up of Indonesian plant and recent capacity additions | Phased commissioning across 2023-2024; initial run rates typically 50-80% of nameplate | Higher unit costs, delayed EBITDA contribution |
| FX Risk | Cross‑currency sales and costs (USD/CNY/IDR) | Exchange rate moves of ~5-10%/yr can alter translated results | Volatile reported revenue and debt servicing costs |
| Regulatory Risk | Environmental and mining policy changes | Stricter emissions/permit standards adopted in multiple jurisdictions since 2021 | Capex increases, project delays, potential fines |
| Competitive Risk | Global producers and integrated converters | Aggregate new industry spodumene capacity additions visible in 2023-2025 pipeline | Price competition, contract renegotiation risk |
| Supply Chain Risk | Raw material, chemical inputs, logistics | Shipping rate volatility and occasional port delays; single‑source risks for key inputs | Production shortfalls, higher working capital, lost sales |
- Balance sheet and liquidity sensitivity: with commodity price pressure, working capital tied in inventories and receivables can increase; access to short‑term financing and ability to refinance project debt become key contingencies.
- Contract exposure: long‑term offtake pricing vs spot exposure - the mix of contracted sales and spot sales determines earnings volatility when prices are weak.
Chengxin Lithium Group Co., Ltd. (002240.SZ) - Growth Opportunities
Chengxin Lithium Group Co., Ltd. (002240.SZ) has several near‑ and medium‑term growth drivers that can reshape revenue visibility and margin profile for investors. Key quantifiable developments and strategic initiatives are summarized below.
- Five‑year supply agreement with Huayou Holding Group: purchase commitment of 221,400 tonnes of lithium salt products, with a total potential value of ¥17.2 billion (implying an average annual supply of ~44,280 tonnes and average annual contract value of ~¥3.44 billion).
- Commencement of sales from the Indonesian plant: anticipated to contribute incremental revenue and diversify feedstock/sales footprint outside China.
- Exploration of international projects in Argentina and Zimbabwe to secure upstream resources and expand global resource base.
- Ongoing investments in R&D to improve product quality (higher purity salts, specialty grades) and develop new applications that can command premium pricing.
- Initiatives on sustainability and responsible mining to align with institutional buyer requirements and ESG‑linked financing opportunities.
- Pursuit of strategic partnerships and joint ventures to accelerate capacity build‑out, de‑risk projects, and deepen access to key customers and feedstock.
| Item | Detail | Implied Annual Metric |
|---|---|---|
| Huayou 5‑year supply agreement | 221,400 tonnes lithium salts; total contract value ¥17.2 billion | ~44,280 tpa; ~¥3.44 billion p.a. |
| Indonesian plant | Sales commencement expected to drive near‑term revenue (first commercial deliveries announced by company) | Material uplift to export mix and revenue diversification |
| International pipeline | Argentina & Zimbabwe: exploration/feasibility activity underway; aims to secure upstream feedstock | Potential long‑term resource addition (subject to project approvals) |
Specific investor considerations tied to these growth opportunities:
- Contracted demand visibility: The Huayou deal provides multi‑year revenue visibility (¥17.2 billion over five years) that can raise baseline utilization and reduce spot exposure.
- Revenue mix shift: Indonesian sales should increase export volumes and may improve realized prices if product grades align with battery‑grade specs.
- Capital allocation: R&D and international expansion will require continued capex and JV capital - monitor company capex guidance and potential equity or project financing.
- ESG and offtake premium: Sustainability initiatives and traceability efforts can help capture premium pricing from EV and battery manufacturers focused on responsible sourcing.
- Execution risk: Project timelines (Indonesian ramp, Argentina/Zimbabwe milestones) and commodity price cycles remain key drivers of near‑term earnings volatility.
For context on Chengxin Lithium Group's strategic framing and stated long‑term goals, see: Mission Statement, Vision, & Core Values (2026) of Chengxin Lithium Group Co., Ltd.

Chengxin Lithium Group Co., Ltd. (002240.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.